Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 11/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.55 |
| ▸ | MAP4K3 | Q8IVH8 | 2/20 | 0.51 |
| ▸ | GRK5 | P34947 | 11/20 | 0.51 |
| ▸ | GRK2 | P25098 | 8/20 | 0.51 |
| ▸ | FLT3 | P36888 | 4/20 | 0.51 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2749999 | 0.99 | MET (0.56) | METKCNH2MAP4K3GRK5GRK2 | |
| SCHEMBL2748933 | 0.87 | MET (0.60) | METKCNH2MAP4K3GRK5GRK2 | |
| Hydrochloric Acid SCHEMBL2748865 | 0.86 | MET (0.57) | METKCNH2MAP4K3GRK5GRK2 | |
| SCHEMBL2749789 | 0.86 | MET (0.59) | METKCNH2MAP4K3GRK5GRK2 | |
| SCHEMBL2747708 | 0.86 | MET (0.59) | METKCNH2MAP4K3GRK5GRK2 | |
| SCHEMBL2750794 | 0.86 | MET (0.59) | METKCNH2MAP4K3GRK5GRK2 | |
| SCHEMBL3804458 | 0.85 | GRK5 (0.60) | METKCNH2MAP4K3GRK5GRK2 | |
| SCHEMBL3803353 | 0.85 | MET (0.56) | METKCNH2MAP4K3GRK5GRK2 | |
| Hydrochloric Acid SCHEMBL2749705 | 0.85 | GRK5 (0.59) | METKCNH2MAP4K3GRK5GRK2 | |
| Hydrochloric Acid SCHEMBL2749773 | 0.85 | MET (0.56) | METKCNH2MAP4K3GRK5GRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090197862-A1 | 2-AMINOPYRIDINE KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. | 2009-08-06 | — | — | US | claimed |
| US-20090197862-A1 | 2-AMINOPYRIDINE KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. | 2009-08-06 | — | — | US | disclosed |
| US-20090197862-A1 | 2-AMINOPYRIDINE KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. | 2009-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197862-A1 | 2-AMINOPYRIDINE KINASE INHIBITORS | ERBB2, ABL2, TIE1 | MET 38/4885KCNH2 1141/4885MAP4K3 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.